O26.42 Herpes gestationis, second trimester

Name of the Condition

• Herpes gestationis, second trimester
• ICD Code: O26.42

Summary

Herpes gestationis is a rare autoimmune blistering disorder that occurs during pregnancy, typically presenting in the second or third trimester. It is characterized by pruritic (itchy) papules and vesicles, primarily affecting the abdomen, trunk, and extremities. The condition is not related to herpes simplex virus but is linked to immune system changes during pregnancy. It usually resolves postpartum but may recur in subsequent pregnancies or with hormonal changes.

Causes

Herpes gestationis is an autoimmune disorder where the immune system produces antibodies targeting components of the skin, particularly the basement membrane zone. The exact trigger is unclear, but it is associated with pregnancy-related hormonal shifts and may involve genetic predisposition. The condition is not infectious and does not result from viral infection.

Risk Factors

Risk factors include a personal or family history of autoimmune diseases, such as thyroid disorders or celiac disease. Women with a history of herpes gestationis in prior pregnancies are at higher risk of recurrence. The condition is more common in first pregnancies and may be associated with certain HLA (human leukocyte antigen) types.

Symptoms

Symptoms include intense itching (pruritus) followed by the development of red, raised papules or vesicles. Lesions may spread to the trunk, extremities, and mucous membranes. The rash often starts on the abdomen and can become widespread. Symptoms typically worsen during pregnancy and improve postpartum.

Diagnosis

Diagnosis is based on clinical presentation, including pruritic rash and blistering, and confirmed by skin biopsy and direct immunofluorescence testing. Laboratory tests may show elevated eosinophils or positive anti-p200 antibodies. The timing of onset (second trimester) and resolution postpartum support the diagnosis.

Treatment Options

Treatment focuses on symptom relief and may include topical or systemic corticosteroids to reduce inflammation and itching. Antihistamines can help manage pruritus. Severe cases may require oral corticosteroids or other immunosuppressants. Close monitoring of maternal and fetal health is essential.

Prognosis and Follow-Up

The condition typically resolves after delivery, though symptoms may persist for weeks. Recurrence in future pregnancies is possible. Long-term follow-up may be needed if complications arise. Fetal outcomes are generally good, but rare cases of transient neonatal blistering have been reported.

Complications

Complications can include secondary skin infections from scratching, severe itching affecting quality of life, and rare cases of fetal involvement (e.g., transient neonatal blistering). Maternal discomfort and potential scarring may occur if lesions are extensive.

Lifestyle & Prevention

Avoiding triggers like excessive heat or friction may help reduce symptoms. Gentle skin care, including moisturizers and loose clothing, can minimize irritation. Prenatal care and early intervention are key to managing symptoms and preventing complications.

When to Seek Professional Help

Seek medical attention if itching becomes severe, lesions spread rapidly, or signs of infection (e.g., pus, fever) develop. Prompt evaluation is important for accurate diagnosis and treatment to ensure maternal and fetal well-being.

Tips for Medical Coders

Document the timing of onset (second trimester) and clinical features (pruritic rash, blistering) to support the O26.42 code. Include details on diagnostic tests (e.g., biopsy, immunofluorescence) and treatment approaches. Ensure documentation aligns with the autoimmune nature of the condition and its pregnancy-specific presentation.